163 related articles for article (PubMed ID: 26728921)
1. HPV 16E7 and 48E7 proteins use different mechanisms to target p130 to overcome cell cycle block.
Nor Rashid N; Yong ZL; Yusof R; Watson RJ
Virol J; 2016 Jan; 13():2. PubMed ID: 26728921
[TBL] [Abstract][Full Text] [Related]
2. Disruption of repressive p130-DREAM complexes by human papillomavirus 16 E6/E7 oncoproteins is required for cell-cycle progression in cervical cancer cells.
Nor Rashid N; Yusof R; Watson RJ
J Gen Virol; 2011 Nov; 92(Pt 11):2620-2627. PubMed ID: 21813705
[TBL] [Abstract][Full Text] [Related]
3. Disruption of pocket protein dream complexes by E7 proteins of different types of human papillomaviruses.
Nor Rashid N; Yusof R; Watson RJ
Acta Virol; 2013; 57(4):447-51. PubMed ID: 24294959
[TBL] [Abstract][Full Text] [Related]
4. Proteasomal degradation of p130 facilitate cell cycle deregulation and impairment of cellular differentiation in high-risk Human Papillomavirus 16 and 18 E7 transfected cells.
Gandhi S; Nor Rashid N; Mohamad Razif MF; Othman S
Mol Biol Rep; 2021 Jun; 48(6):5121-5133. PubMed ID: 34169395
[TBL] [Abstract][Full Text] [Related]
5. Casein kinase II motif-dependent phosphorylation of human papillomavirus E7 protein promotes p130 degradation and S-phase induction in differentiated human keratinocytes.
Genovese NJ; Banerjee NS; Broker TR; Chow LT
J Virol; 2008 May; 82(10):4862-73. PubMed ID: 18321970
[TBL] [Abstract][Full Text] [Related]
6. Structural mechanisms of DREAM complex assembly and regulation.
Guiley KZ; Liban TJ; Felthousen JG; Ramanan P; Litovchick L; Rubin SM
Genes Dev; 2015 May; 29(9):961-74. PubMed ID: 25917549
[TBL] [Abstract][Full Text] [Related]
7. E7 properties of mucosal human papillomavirus types 26, 53 and 66 correlate with their intermediate risk for cervical cancer development.
Mansour M; Touka M; Hasan U; Bellopede A; Smet A; Accardi R; Gabet AS; Sylla BS; Tommasino M
Virology; 2007 Oct; 367(1):1-9. PubMed ID: 17568647
[TBL] [Abstract][Full Text] [Related]
8. A B-myb--DREAM complex is not critical to regulate the G2/M genes in HPV-transformed cell lines.
Rashid NN; Yusof R; Watson RJ
Anticancer Res; 2014 Nov; 34(11):6557-63. PubMed ID: 25368258
[TBL] [Abstract][Full Text] [Related]
9. Inorganic arsenic exposure induces E2F-dependent G0/G1 arrest via an increase in retinoblastoma family protein p130 in B-cell lymphoma A20 cells.
Okamura K; Miki D; Nohara K
Genes Cells; 2013 Oct; 18(10):839-49. PubMed ID: 23890198
[TBL] [Abstract][Full Text] [Related]
10. Evolutionarily conserved multisubunit RBL2/p130 and E2F4 protein complex represses human cell cycle-dependent genes in quiescence.
Litovchick L; Sadasivam S; Florens L; Zhu X; Swanson SK; Velmurugan S; Chen R; Washburn MP; Liu XS; DeCaprio JA
Mol Cell; 2007 May; 26(4):539-51. PubMed ID: 17531812
[TBL] [Abstract][Full Text] [Related]
11. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.
Goodwin EC; DiMaio D
Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12513-8. PubMed ID: 11070078
[TBL] [Abstract][Full Text] [Related]
12. Destabilization of the retinoblastoma tumor suppressor by human papillomavirus type 16 E7 is not sufficient to overcome cell cycle arrest in human keratinocytes.
Helt AM; Galloway DA
J Virol; 2001 Aug; 75(15):6737-47. PubMed ID: 11435552
[TBL] [Abstract][Full Text] [Related]
13. The E7 proteins of low- and high-risk human papillomaviruses share the ability to target the pRB family member p130 for degradation.
Zhang B; Chen W; Roman A
Proc Natl Acad Sci U S A; 2006 Jan; 103(2):437-42. PubMed ID: 16381817
[TBL] [Abstract][Full Text] [Related]
14. Restoring the DREAM Complex Inhibits the Proliferation of High-Risk HPV Positive Human Cells.
James CD; Saini S; Sesay F; Ko K; Felthousen-Rusbasan J; Iness AN; Nulton T; Windle B; Dozmorov MG; Morgan IM; Litovchick L
Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33513914
[TBL] [Abstract][Full Text] [Related]
15. The association of mammalian DREAM complex and HPV16 E7 proteins.
Rashid NN; Rothan HA; Yusoff MS
Am J Cancer Res; 2015; 5(12):3525-33. PubMed ID: 26885443
[TBL] [Abstract][Full Text] [Related]
16. A Reverse Structure-based Design of HPV E7 Inhibitor.
Tan WC; Othman S; Lim SK; Rashid NN; Heh CH
Curr Comput Aided Drug Des; 2022; 18(4):318-325. PubMed ID: 35538818
[TBL] [Abstract][Full Text] [Related]
17. Site-directed mutant p21 proteins defective in both inhibition of E2F-regulated transcription and disruption of E2F-p130-cyclin-cdk2 complexes.
Robles SJ; Shiyanov P; Aristodemo GT; Raychaudhuri P; Adami GR
DNA Cell Biol; 1998 Jan; 17(1):9-18. PubMed ID: 9468218
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus type 16 E7 perturbs DREAM to promote cellular proliferation and mitotic gene expression.
DeCaprio JA
Oncogene; 2014 Jul; 33(31):4036-8. PubMed ID: 24166507
[TBL] [Abstract][Full Text] [Related]
19. Accumulation of human papillomavirus type 16 E7 protein bypasses G1 arrest induced by serum deprivation and by the cell cycle inhibitor p21.
Morozov A; Shiyanov P; Barr E; Leiden JM; Raychaudhuri P
J Virol; 1997 May; 71(5):3451-7. PubMed ID: 9094616
[TBL] [Abstract][Full Text] [Related]
20. Cyclin D-CDK4 relieves cooperative repression of proliferation and cell cycle gene expression by DREAM and RB.
Schade AE; Oser MG; Nicholson HE; DeCaprio JA
Oncogene; 2019 Jun; 38(25):4962-4976. PubMed ID: 30833638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
